NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 08 04:00PM ET
1.46
Dollar change
-0.02
Percentage change
-1.35
%
Index- P/E- EPS (ttm)-1.30 Insider Own52.64% Shs Outstand21.33M Perf Week2.82%
Market Cap31.14M Forward P/E- EPS next Y-1.37 Insider Trans0.56% Shs Float10.10M Perf Month5.04%
Enterprise Value49.86M PEG- EPS next Q-0.30 Inst Own8.41% Short Float1.04% Perf Quarter2.82%
Income-26.57M P/S148.29 EPS this Y16.61% Inst Trans11.48% Short Ratio4.82 Perf Half Y-5.19%
Sales0.21M P/B- EPS next Y-9.99% ROA-224.54% Short Interest0.11M Perf YTD2.10%
Book/sh-1.14 P/C5.86 EPS next 5Y- ROE-237.08% 52W High3.99 -63.41% Perf Year-37.61%
Cash/sh0.25 P/FCF- EPS past 3/5Y-581.66% - ROIC- 52W Low1.21 20.66% Perf 3Y-84.98%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin-284.43% Volatility7.46% 7.00% Perf 5Y-
Dividend TTM- EV/Sales237.43 EPS Y/Y TTM-153.52% Oper. Margin-9181.60% ATR (14)0.11 Perf 10Y-
Dividend Ex-Date- Quick Ratio0.88 Sales Y/Y TTM-9.40% Profit Margin-12534.91% RSI (14)48.51 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio1.09 EPS Q/Q8.60% SMA200.69% Beta2.20 Target Price7.12
Payout- Debt/Eq- Sales Q/Q-22.03% SMA50-3.12% Rel Volume0.90 Prev Close1.48
Employees42 LT Debt/Eq- EarningsMay 01 AMC SMA200-19.33% Avg Volume21.89K Price1.46
IPOApr 29, 2021 Option/ShortNo / Yes EPS/Sales Surpr.18.88% -29.23% Trades Volume19,585 Change-1.35%
Date Action Analyst Rating Change Price Target Change
Jun-24-24Initiated Ascendiant Capital Markets Buy $8.50
Jul-08-25 08:00AM
Jul-01-25 08:00AM
Jun-26-25 08:00AM
Jun-13-25 08:35AM
Jun-11-25 08:30AM
02:38PM Loading…
Jun-10-25 02:38PM
08:30AM
May-13-25 09:15AM
May-01-25 12:30PM
Apr-22-25 06:00AM
Mar-31-25 09:15AM
Mar-17-25 09:25AM
Mar-12-25 09:00AM
Mar-10-25 09:00AM
Feb-24-25 09:25AM
09:15AM Loading…
Feb-14-25 09:15AM
Dec-19-24 09:00AM
Dec-16-24 09:00AM
Nov-14-24 08:38AM
Nov-12-24 09:25AM
Nov-08-24 09:25AM
Nov-01-24 08:00AM
Oct-24-24 08:00AM
Oct-23-24 08:00AM
Oct-22-24 08:00AM
Oct-01-24 08:00AM
Sep-23-24 08:00AM
Sep-16-24 09:00AM
Aug-28-24 08:00AM
Aug-12-24 08:34AM
08:00AM Loading…
Jul-31-24 08:00AM
Jul-01-24 08:00AM
Jun-11-24 08:00AM
Jun-06-24 09:00AM
Jun-05-24 08:00AM
May-15-24 10:53PM
04:05PM
Apr-29-24 09:00AM
Apr-24-24 08:00AM
Apr-03-24 08:05AM
Apr-02-24 10:53PM
08:00AM
Mar-12-24 10:52AM
Mar-04-24 09:20AM
Feb-07-24 09:00AM
Feb-05-24 11:00AM
Jan-30-24 08:05AM
Jan-22-24 09:30AM
09:00AM
Dec-04-23 08:15AM
Nov-20-23 07:30AM
Nov-10-23 09:00AM
Nov-01-23 07:00AM
Oct-31-23 07:00AM
Oct-24-23 09:00AM
Oct-19-23 08:00AM
Oct-10-23 08:30AM
Oct-03-23 08:00AM
Oct-02-23 07:00AM
Envoy Medical, Inc. is a hearing health company, which engages in providing medical technologies across the hearing loss spectrum. It focuses on designing, developing, and marketing fully implantable medical devices that improve hearing. The company was founded in 1995 and is headquartered in White Bear Lake, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Patel Mona ChetanDirectorJun 11 '25Buy1.472,5003,67520,000Jun 13 04:10 PM
Patel Mona ChetanDirectorJun 06 '25Buy1.4610,00014,60017,500Jun 10 04:11 PM
BRYNELSEN CHARLESDirectorMay 27 '25Buy1.6535,00057,67350,000May 27 06:34 PM
BRYNELSEN CHARLESDirectorMay 23 '25Buy1.6413,00021,36315,000May 27 06:34 PM
BRYNELSEN CHARLESDirectorMay 22 '25Buy1.682,0003,3672,000May 27 06:34 PM
Patel Mona ChetanDirectorNov 20 '24Buy2.282,5005,6997,500Nov 22 04:32 PM
Patel Mona ChetanDirectorSep 11 '24Buy3.334,00013,3205,000Sep 11 04:50 PM
Patel Mona ChetanDirectorSep 09 '24Buy3.201,0003,2001,000Sep 11 04:50 PM